Brief: Xortx Receives Further No Objection Letter From Health Canada
26/10/2022 12:11
Oct 26 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX RECEIVES FURTHER NO OBJECTION LETTER FROM HEALTH
CANADA
* XORTX THERAPEUTICS INC - RECEIPT OF A FURTHER NOL FROM
HEALTH
CANADA REGARDING ONGOING XRX-OXY101 CLINICAL BRIDGING
PHARMACOKINETICS STUDY
Source text for Eikon: ID:nGNXd9jCK
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering